Loading clinical trials...
Loading clinical trials...
Comparing the Efficacy and Safety of Pregabalin Monotherapy With Pregabalin Combined Dexmedetomidine in the Treatment of Fibromyalgia: A Multicenter Clinical Study
Conditions
Interventions
Pregabalin
Pregabalin with dexmedetomidine
Locations
1
China
Beijing Tiantan Hospital, Beijing, Beijing 100070
Beijing, China
Start Date
September 30, 2025
Primary Completion Date
June 30, 2027
Completion Date
August 31, 2027
Last Updated
November 28, 2025
NCT07358754
NCT05901259
NCT03759522
NCT07398417
NCT07230171
NCT07186751
Lead Sponsor
Beijing Tiantan Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions